All News

Viral/Non-Viral Vectors

Lenti- vs Retro-, and Increasing Capacity for Multi-Vector Development
8 August 2022
Lenti- vs Retro-, and Increasing Capacity for Multi-Vector Development
In this interview, we explore
Viral vs Non-Viral Vectors
4 August 2022
Viral vs Non-Viral Vectors
For this feature, the Phacilitate
FDA Gives Go-Ahead for New Gene Therapy Clinical Trial in Cystic Fibrosis
2 August 2022
FDA Gives Go-Ahead for New Gene Therapy Clinical Trial in Cystic Fibrosis
Pivotal-stage gene therapy company Krystal
First Patient Successfully Treated by Ex Vivo Lentiviral Gene Therapy for RAG1-SCID
1 August 2022
First Patient Successfully Treated by Ex Vivo Lentiviral Gene Therapy for RAG1-SCID
Mustang Bio has announced that
POPULAR NEWS ITEMS
Image
11 August 2022

GentiBio Collab with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for IBD

Image
10 August 2022

Stevenage Bioscience Hub’s Lab Hotel Joined by Inspira Pharmaceuticals

Image
9 August 2022

Pfizer Acquire Global Blood Therapeutics for $5.4 Billion

Gene Therapy and the Big Debate: Viral Vectors Vs Non-Viral Vectors
29 July 2022
Gene Therapy and the Big Debate: Viral Vectors Vs Non-Viral Vectors
As gene therapies expand their
Sustainably Scaling Up AAV with Insect Cell Lines: in Discussion with Porton Advanced
11 July 2022
Sustainably Scaling Up AAV with Insect Cell Lines: in Discussion with Porton Advanced
For this blog post, the
Two bluebird bio Gene Therapies Achieve Unanimous FDA Support
16 June 2022
Two bluebird bio Gene Therapies Achieve Unanimous FDA Support
Bluebird bio celebrates a big
Key Takeaways from ASGCT 2022
25 May 2022
Key Takeaways from ASGCT 2022
Ryan Leahy summarizes his key
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

GentiBio Collab with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for IBD

Image

Stevenage Bioscience Hub’s Lab Hotel Joined by Inspira Pharmaceuticals

Image

Pfizer Acquire Global Blood Therapeutics for $5.4 Billion